Global health initiatives: latest news

Global health initiatives features

Global health initiatives news from aidsmap

More news

Global health initiatives news selected from other sources

  • A UNAIDS–Lancet Commission on Defeating AIDS—Advancing Global Health

    The UNAIDS–Lancet Commission has come together at a moment when the lessons of the AIDS response, including its whole-of-society perspective, can be informative and even transformational for other spheres of global health. The path to ending AIDS as a public health threat by 2030, as set out in this report, should be a major part of the post-2015 development agenda.

    25 June 2015 | The Lancet
  • US funding for HIV treatment linked with employment gains in sub-Saharan Africa

    We found that PEPFAR was associated with a 13 percent increase in employment among males in focus nations compared to non-focus ones. In contrast, no change in employment was observed among females. In addition, we found that increasing PEPFAR per capita funding by $100 was associated with a 9.1-percentage-point average increase in employment among males.

    15 June 2015 | Brookings Institution (blog)
  • UNITAID brings innovation to the global response to HIV/AIDS, TB and Malaria

    At a meeting in Rio de Janeiro, the Executive Board announced it would as a first step focus investments in three areas: improving antiretroviral therapy for adults in low and middle-income countries; enabling the expanded use, or "scale-up", of first pre-exposure prophylaxis (PrEP) as a means of preventing HIV transmission; and the development of better tools to diagnose hepatitis C virus (HCV), in particular for people who are co-infected with HIV/HCV.

    08 June 2015 | UNITAID
  • Obama’s AIDS Boss Appeals to Apax, Nike for Help to Curb HIV

    Deborah Birx wants to wring more from the $6.8 billion the U.S. gives her each year to fight AIDS around the world. Hampered by a stagnant budget, she’s cutting off funding to clinics that fail to find HIV cases and looking to Starbucks Corp. and Nike Inc. for ideas.

    03 June 2015 | Bloomberg
  • The HIV 'emergency' isn't over, says PEPFAR chief

    Ambassador Deborah Birx, U.S. global AIDS coordinator and director of the largest initiative to combat a single disease, talks data, PEPFAR's future and the AIDS emergency we still face in this video interview.

    28 May 2015 | Devex
  • UNAIDS welcomes further evidence that starting antiretroviral therapy early saves lives

    “Every person living with HIV should have immediate access to life-saving antiretroviral therapy,” said Michel Sidibé, Executive Director of UNAIDS. “Delaying access to HIV treatment under any pretext is denying the right to health.”

    28 May 2015 | UNAIDS
  • ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV

    ViiV Healthcare, Aurobindo Pharma, and the Clinton Health Access Initiative, Inc. (CHAI) announced today that Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for Tentative Approval, to the Food and Drug Administration (FDA), for the treatment of HIV. This is the first ANDA for a generic version of dolutegravir, less than two years after FDA approval of Tivicay® (dolutegravir) for sale in the United States. Upon receiving Tentative Approval from the FDA, Aurobindo Pharma will be able to supply dolutegravir 50mg via the President’s Emergency Plan for AIDS Relief (PEPFAR) programme, following completion of required local regulatory approval process, in the licensed countries outside of the United States, as per the agreement signed between Aurobindo Pharma and ViiV Healthcare in 2014.

    26 May 2015 | ViiV Healthcare
  • WHO Advances Research and Development Financing Effort; Global R&D Observatory To Launch In January

    World Health Organization members in committee this week took note of a report by the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG), which was set up to find ways to fund research on diseases afflicting poor populations which have little market incentive for the private sector. The report included a proposal for a voluntary pooled fund that would focus on the development of effective and affordable health technologies for such neglected diseases.

    26 May 2015 | Intellectual Property Watch
  • World Health Assembly: Experts discuss delinking drug R&D costs from pricing to make them affordable

    The problem of drug prices eating up national health budgetscame up at the annual World Health Assembly, which took place from 18-26 May. Last week, a panel of experts discussed the merits of lowering those prices by delinking research and development costs from pricing.

    26 May 2015 | Intellectual Property Watch
  • Civil Society Groups Tell UNITAID: Support access mechanisms led by civil society, not the pharmaceutical industry

    Letters from global groups express deep concerns about the Medicines Patent Pool’s entry into hepatitis C treatment.

    05 May 2015 | Hep C Coalition
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.